Showing results (251-260 of 354) with videos related to
Sort By:
Pageof 36
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 26, 2018
The ERA-EDTA today and tomorrow: a progress document by the ERA-EDTA CouncilCarmine Zoccali, Mustafa Arici, Peter J Blankestijn, et al.Arthritis Research & Therapy|July 14, 2022
Cryoglobulinemia in systemic lupus erythematosus: a retrospective study of 213 patientsYoann Roubertou, Sabine Mainbourg, Arnaud Hot, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 25, 2009
Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney diseaseJustine Bacchetta, Stéphanie Boutroy, Nicolas Vilayphiou, et al.British Journal of Clinical Pharmacology|December 28, 2020
Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort studySophie Liabeuf, Oriane Lambert, Marie Metzger, et al.Atherosclerosis|April 3, 2016
Fetuin-A, glycemic status, and risk of cardiovascular disease: The Multi-Ethnic Study of AtherosclerosisSarah A Aroner, David E St-Jules, Kenneth J Mukamal, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2019
The nephrology crystal ball: the medium-term futureCarmine Zoccali, Peter J Blankestijn, Annette Bruchfeld, et al.International Urology and Nephrology|November 20, 2017
From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-κB/Nrf2 expressionMilena B Stockler-Pinto, Christophe O Soulage, Natália A Borges, et al.Lancet (London, England)|May 27, 2014
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failureAlberto Ortiz, Adrian Covic, Danilo Fliser, et al.Clinical Journal of the American Society of Nephrology : CJASN|October 28, 2017
Randomized Clinical Trial of Sevelamer Carbonate on Serum Klotho and Fibroblast Growth Factor 23 in CKDSophie Liabeuf, Jean-Philippe Ryckelynck, Najeh El Esper, et al.Gut Microbes|July 12, 2025
A specifically designed multi-biotic reduces uremic toxin generation and improves kidney functionAlice Beau, Jane Natividad, Berengère Benoit, et al.Pageof 36